Siddharth Kogilwaimath, MD FIDSA
banner
hivdocsk.bsky.social
Siddharth Kogilwaimath, MD FIDSA
@hivdocsk.bsky.social
Infectious Diseases Doc/Associate Professor at UTSW with an interest in HIV. Canadian. Nomad. Views, my own. He/Him/his. 🇨🇦🇮🇳🇧🇳🇲🇾

📍Dallas 🇺🇸
Reposted by Siddharth Kogilwaimath, MD FIDSA
Hear ye, hear ye 📣📣
UT Southwestern is looking for interested candidates for our 1-year HIV Medicine Fellowship!! Apply now!!!
See image for details! #HIVSky #IDSky
August 16, 2025 at 12:19 AM
Reposted by Siddharth Kogilwaimath, MD FIDSA
Come train with some of the absolute best in the field at UT Southwestern!!! #weareUTSWID
July 26, 2025 at 5:07 AM
Anyone know of folks who are interested in low barrier HIVcare models?? Would love to connect!!! @hivma.bsky.social @jncherabiemd.bsky.social @anuhazramd.bsky.social @boghuma.bsky.social @darcy-id-doc.bsky.social #HIVSky
You might be forgiven for thinking its a picture of some clinic staff, but these dedicated professionals strive to deliver a unique low barrier access to HIV care, making us one of a handful locations in the country to offer this care model! @bradcutrellmd.bsky.social
#weareUTSWID
June 6, 2025 at 3:28 PM
Reposted by Siddharth Kogilwaimath, MD FIDSA
Congrats to our fantastic ID fellow (Dr. Hannah Blanchard) and ID Faculty (Dr. Hayden Andrews, Dr. Netanya Utay) on their timely publication in @cidjournal.bsky.social on Measles immunity at our HIV clinic!! 👏
academic.oup.com/cid/advance-...

@bradcutrellmd.bsky.social @netanyautay.bsky.social
June 4, 2025 at 1:51 AM
Reposted by Siddharth Kogilwaimath, MD FIDSA
You might be forgiven for thinking its a picture of some clinic staff, but these dedicated professionals strive to deliver a unique low barrier access to HIV care, making us one of a handful locations in the country to offer this care model! @bradcutrellmd.bsky.social
#weareUTSWID
May 16, 2025 at 1:32 AM
Hi #HIVSky, #MedSky and #IDSky,
Doing a talk on HIV updates for the Internists. Any suggestions or thoughts on what would be helpful/useful??
Thank you! 🙏
March 31, 2025 at 2:40 PM
Reposted by Siddharth Kogilwaimath, MD FIDSA
What does the Parkland HIV team do when not hard at work? We go out to cheer for the Dallas Stars, of course!! #weareUTSWID #Dallasatheart @ellenkitchell.bsky.social @bradcutrellmd.bsky.social
March 11, 2025 at 3:04 AM
Reposted by Siddharth Kogilwaimath, MD FIDSA
In 🇺🇸 military cohort of 1413 (7559 person years) PLWH, cART initiation within 24 months of diagnosis had lower rates of blips than pts starting cART >24 months after diagnosis

academic.oup.com/cid/advance-...

#IDSky
Antiretroviral Therapy within Two Years of HIV Acquisition is Associated with Fewer Viral Blips: A Retrospective Analysis of Over 20 Years of Data from the U.S. Military HIV Natural History Study
Participants who started antiretroviral therapy within up to 24 months after HIV acquisition had lower hazard of viral blips as compared to participants wh
academic.oup.com
March 10, 2025 at 11:48 PM
Going to be missing #CROI2025 but hoping to keep up with @drlaurajwaters.bsky.social @tristanjbarber.bsky.social @sebpoule.bsky.social @jezerlezama.bsky.social wherever you’re posting!! Have a fantastic conference!!
a woman is looking out of a window and says `` dont mind me ... i 'm having fomo '' .
ALT: a woman is looking out of a window and says `` dont mind me ... i 'm having fomo '' .
media.tenor.com
March 9, 2025 at 9:43 PM
Reposted by Siddharth Kogilwaimath, MD FIDSA
« Bulevirtide for the Treatment of Hepatitis Delta; Real-World Cohort from the Canadian HBV Network »

My poster at
CDDW-CLM conference
Quebec City 🇨🇦, now

*Nothing compared to European cohorts, but it’s a start. BLV only for compassionate use here 🤷‍♂️

#IDsky #Liversky #HepSky
February 28, 2025 at 1:40 PM
Anyone else using openevidence.com? What has been your experience? 👀 #IDSky #MedSky #HIVSky
OpenEvidence
The leading medical information platform.
openevidence.com
February 26, 2025 at 10:58 PM
Me when someone explains the US billing codes, vs me, 5 minutes later. #IDmeme
February 19, 2025 at 10:57 PM
January 14, 2025 at 11:08 PM
Thank you @sustainabil-id.bsky.social for inviting me and my colleague, Dr. Govind, to speak on the issue of #HIV and #sustainability. Forced us to delve into this. There are few studies and observations but largely an area we dont talk much about. If anyone is interested, DM me! Love to collaborate
January 12, 2025 at 4:34 PM
Hi #HIVSky,
Just reaching out as I am interested in environmental sustainability” in HIV. Looking for eg of HIV programs that are incorporating sustainable practices with measurable impacts. Also interested in understanding how to decarbonise HIV while striving for the end of the epidemic.
Thank you
January 6, 2025 at 8:39 PM
Reposted by Siddharth Kogilwaimath, MD FIDSA
👇🏾👇🏾👇🏾
jama.com JAMA @jama.com · Dec 1
This Special Communication from the International Antiviral Society–USA provides updated 2024 recommendations for HIV treatment and clinical management and HIV prevention. #WorldAIDSDay

ja.ma/4fOyEI3
December 18, 2024 at 4:11 AM
Reposted by Siddharth Kogilwaimath, MD FIDSA

US based STOMP trial of tecovirimat (tpoxx) for clade 2 mpox fails to demonstrate efficacy benefit. Just as it did not in PALM 007 in clade 1 mpox in DRC.

There is no known treatment for mpox

Vaccination is the key control strategy and more research is needed.
pubmed.ncbi.nlm.nih.gov/38190312/
Early Tecovirimat Treatment for Mpox Disease Among People With HIV - PubMed
Results of this cohort study support starting tecovirimat in all PWH as soon as an mpox diagnosis is suspected. Additional research is warranted to confirm these findings.
pubmed.ncbi.nlm.nih.gov
December 10, 2024 at 11:00 PM
Reposted by Siddharth Kogilwaimath, MD FIDSA
Spotify wrapped, but for antibiotics. What’s yours?
December 7, 2024 at 7:35 PM
Hey #HIVSky #IDSky #MedSky, if you, or anyone you know, might be interested!!! 👇
🌟 Exciting Opportunity! 🌟 UTSW's HIV Fellowship is seeking candidates passionate about HIV medicine & health equity. Open to qualified applicants, including those without prior US training.

👉 Apply now: www.utsouthwestern.edu/departments/...
#HIVMedicine #UTSW
HIV Medicine Fellowship Overview
www.utsouthwestern.edu
December 6, 2024 at 11:46 AM
Reposted by Siddharth Kogilwaimath, MD FIDSA
Important work led by former UAB CMR and @utswinfdis.bsky.social own ID fellow Julie England and her mentors Drs. Walker, Lee and colleagues! #IDSky @ricardolahozmd.bsky.social @hivdocsk.bsky.social
One of the most controversial diagnoses in ECMO is VAP.

New proposed ECMO-associated pneumonia proposed by UAB:
1) Worsening O2 by flow/sweep changes
2) 🔺 temperature or WBC
3) Pos quantitative BAL or endotracheal aspirate

#IDSky

www.cambridge.org/core/journal...
Analysis of diagnostic criteria for ECMO-associated pneumonia | Infection Control & Hospital Epidemiology | Cambridge Core
Analysis of diagnostic criteria for ECMO-associated pneumonia
www.cambridge.org
December 6, 2024 at 2:42 AM
WOHOO!!! Welcome to the bluer skies Ellen!!!

Hey #IDSky and #HIVSky, please give my amazing colleague and someone I look up to, a follow. She’s a trail blazing clinician and kicks HIV’s bu*t every day!!!

@utswinfdis.bsky.social
Buenas from Dallas!

On my friend Sidd's suggestion (@hivdocsk.bsky.social), I'm looking forward to drawing strength from my ID/HIV community here! Looking forward to interesting conversations with #IDSky and @HIVsky. Y'all are the best!
December 6, 2024 at 1:19 AM
Lets gooooooo!!!
November 30, 2024 at 4:46 AM
#IDSky

Looking for strategies to get students interested in ID when on incredibly busy service weeks and its their only exposure to ID!!

@darcy-id-doc.bsky.social @germhuntermd.bsky.social @bradcutrellmd.bsky.social @idvilchez.bsky.social
November 30, 2024 at 2:47 AM
Reposted by Siddharth Kogilwaimath, MD FIDSA
November 27, 2024 at 8:01 PM